[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Ion Beam Applications SA (IBAB) - Financial and Strategic SWOT Analysis Review

July 2021 | 53 pages | ID: I2E0BA290C1EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Ion Beam Applications SA (IBAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Ion Beam Applications SA (IBA) develops solutions for the diagnosis and treatment of cancer and other serious illnesses. The company offers monitoring equipment and software that enables hospitals to perform calibration procedures during radiation therapy and radiology. The medical technology company focuses its activities on proton therapy solutions, dosimetry, and other accelerators. The company’s products and services find application in the treatment of cancer, and neurologic and cardiac disorders. It also provides sterilization and ionization solutions for industrial uses. The company has operational presence across the US, Europe, and Asia. IBA is headquartered in Louvain la Neuve, Walloon Brabant, Belgium.

Ion Beam Applications SA Key Recent Developments

Jun 29,2021: Iba Launch of a New Share Buyback Program
May 27,2021: Ion Beam Applications (Iba) Acquisition of Own Shares Completion of the Share Buyback Program
Feb 11,2021: IBA–Acquisition of Own Shares
Feb 04,2021: Iba – Acquisition of Own Shares
Jan 21,2021: IBA: Year 2020 trading update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Ion Beam Applications SA - Key Facts
Ion Beam Applications SA - Key Employees
Ion Beam Applications SA - Key Employee Biographies
Ion Beam Applications SA - Major Products and Services
Ion Beam Applications SA - History
Ion Beam Applications SA - Company Statement
Ion Beam Applications SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Ion Beam Applications SA - Business Description
Business Segment: Dosimetry
Overview
Performance
Business Segment: Proton Therapy(PT) and Other Accelerator
Overview
Performance
Geographical Segment: Belgium
Performance
Geographical Segment: Rest of the World (ROW)
Performance
Geographical Segment: The US
Performance
R&D Overview
Ion Beam Applications SA - SWOT Analysis
SWOT Analysis - Overview
Ion Beam Applications SA - Strengths
Ion Beam Applications SA - Weaknesses
Ion Beam Applications SA - Opportunities
Ion Beam Applications SA - Threats
Ion Beam Applications SA - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Ion Beam Applications SA, Medical Equipment, Deals By Year, 2015 to YTD 2021
Ion Beam Applications SA, Medical Equipment, Deals By Type, 2015 to YTD 2021
Ion Beam Applications SA, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Jan 21, 2021: IBA: Year 2020 trading update
Nov 19, 2020: IBA business update – third quarter 2020
Sep 15, 2020: IBA selected to equip IRE's new radioisotope production unit dedicated to cancer diagnosis
Aug 27, 2020: IBA signs €100m licensing deal for proton therapy solution in China
Aug 26, 2020: IBA reports half year 2020 results
May 13, 2020: IBA business update first quarter 2020
Mar 26, 2020: IBA reports full year 2019 results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Ion Beam Applications SA, Key Facts
Ion Beam Applications SA, Key Employees
Ion Beam Applications SA, Key Employee Biographies
Ion Beam Applications SA, Major Products and Services
Ion Beam Applications SA, History
Ion Beam Applications SA, Subsidiaries
Ion Beam Applications SA, Key Competitors
Ion Beam Applications SA, Ratios based on current share price
Ion Beam Applications SA, Annual Ratios
Ion Beam Applications SA, Annual Ratios (Cont...1)
Ion Beam Applications SA, Annual Ratios (Cont...2)
Ion Beam Applications SA, Interim Ratios
Ion Beam Applications SA, Medical Equipment, Deals By Year, 2015 to YTD 2021
Ion Beam Applications SA, Medical Equipment, Deals By Type, 2015 to YTD 2021
Ion Beam Applications SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Ion Beam Applications SA, Performance Chart (2016 - 2020)
Ion Beam Applications SA, Ratio Charts
Ion Beam Applications SA, Medical Equipment, Deals By Year, 2015 to YTD 2021
Ion Beam Applications SA, Medical Equipment, Deals by Type, 2015 to YTD 2021


More Publications